INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Building Patient-Centric Cardiovascular Endpoints With Continuous Digital Measures

  Cardiovascular trial teams learn how wearable sensors can strengthen activity and heart health measures while easing patient burden.

• Medical Monitoring Oversight And Real-Time Data In Clinical Trials

  Explore how real-time access to safety data is changing medical monitoring, with insights into continuous analysis, remote data visibility, and what these shifts mean for protecting patients.

• Own Your Data, Accelerate Your Cure

  Move from passive donor to active innovator. Explore how patient communities are building their own research infrastructure and using AI to bypass traditional barriers to drug development.

• Align eDiary Design With Assessment Schedules

  Ensure alignment with your study protocol by leveraging the Sculptor portal to simulate eDiary completion and top-down scheduling, allowing for real-time preview and modifications.

• Build Or Buy: Adopting AI Agents In Life Sciences

  1/8/2026

  Should your team build custom AI agents from scratch or partner with a ready-made solution? This practical guide cuts through the hype to reveal the strategic insights you need.

• How AI Is Reshaping Clinical Development And Trial Execution

  8/6/2026

  See how AI, real-world data, and agentic technologies are helping clinical teams improve patient selection, streamline operations, and speed trial outcomes.

• Stop Settling For "Real Time." It's Time To Go Live.

  7/18/2026

  By the time a trial record is reviewed, the moment to act has often passed. Discover how point-of-care data capture supports proactive, not retrospective, oversight.

• Medical Device Clinical Trials: Key Considerations For Sponsors And CROs

  3/30/2026

  Medical device trials must align risk class, regulations, and study design. Strong oversight, data, and proactive safety planning support reliable evidence and market approval.

• Critical Imaging Risks In GLP-1 And Neurology Studies

  5/27/2025

  As imaging grows in importance within GLP-1 and neurology trials, it must be treated not as a routine task but as a strategic pillar that supports participant safety and reproducible outcomes.